|
Apr 16
|
CRISPR Therapeutics AG (CRSP) Stock Sinks As Market Gains: What You Should Know
|
|
Apr 15
|
CRISPR Therapeutics' (NASDAQ:CRSP) investors will be pleased with their favorable 63% return over the last five years
|
|
Apr 13
|
3 Magnificent Stocks That Could Double or More by 2030
|
|
Apr 11
|
Charles River (CRL) Forges Collaboration With Ship of Theseus
|
|
Apr 10
|
Innovation in Healthcare: HTEC’s Q1 2024 Index Rebalance
|
|
Apr 9
|
CRISPR Therapeutics AG (CRSP) Exceeds Market Returns: Some Facts to Consider
|
|
Apr 9
|
Better Buy: CRISPR Therapeutics Vs. Viking Therapeutics
|
|
Apr 5
|
Better Growth Biotech Buy: Iovance Biotherapeutics vs CRISPR Therapeutics
|
|
Apr 3
|
CRISPR Therapeutics to Present at the Annual Needham Virtual Healthcare Conference
|
|
Apr 1
|
CRISPR Therapeutics to Present at the American Society of Gene & Cell Therapy (ASGCT) 2024 Annual Meeting
|
|
Mar 30
|
3 Unstoppable Stocks to Buy Hand Over Fist in April
|
|
Mar 28
|
3 Biotech Stocks That Could Be Multibaggers in the Making: March Edition
|
|
Mar 27
|
3 No-Brainer Healthcare Stocks to Buy Right Now for Less Than $1,000
|
|
Mar 25
|
CRISPR Therapeutics AG (CRSP) Sees a More Significant Dip Than Broader Market: Some Facts to Know
|
|
Mar 24
|
Cathie Wood’s Stock Portfolio: 2024 Stock Picks
|
|
Mar 23
|
Buying These Dirt-Cheap Stocks Could Be a Brilliant Move
|
|
Mar 22
|
CRISPR Therapeutics (CRSP) Down 13.6% Since Last Earnings Report: Can It Rebound?
|
|
Mar 21
|
3 Stocks That Could Be the Next Big Thing in Gene Editing
|
|
Mar 20
|
3 Biopharma Stocks Predicted to Soar in Q2 2024
|
|
Mar 19
|
CRISPR Therapeutics AG (CRSP) Outperforms Broader Market: What You Need to Know
|